L. Myeroff

发表

SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers

C. Plass, J. Issa, Hui Li, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Discovery and Scoring of Protein Interaction Subnetworks Discriminative of Late Stage Human Colon Cancer*S

Rod K. Nibbe, L. Myeroff, S. Markowitz, 2009, Molecular & Cellular Proteomics.

HLTF gene silencing in human colon cancer

C. Plass, J. Minna, J. Issa, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Epigenomic Enhancer Profiling Defines a Signature of Colon Cancer

Jason H. Moore, T. LaFramboise, Richard Cowper-Sal·lari, 2012, Science.

Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits

M. Lupien, L. Myeroff, J. Willis, 2014, Genome research.

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

K. Kinzler, B. Vogelstein, L. Myeroff, 1995, Science.

H3K4me3 inversely correlates with DNA methylation at a large class of non-CpG-island-containing start sites

G. Crawford, L. Myeroff, J. Lutterbaugh, 2012, Genome Medicine.

BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells.

D. Carrasco, Yunyu Zhang, K. Anderson, 2009, Cancer research.

Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome

James J. Morrow, Shondra M. Pruett-Miller, J. Bradner, 2017, Nature Communications.

Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor β resistant cells

L. Myeroff, J. Willson, S. Markowitz, 2008, Genes, chromosomes & cancer.

Receptor Type II in Microsatellite Stable Colon Cancers β Mutational Inactivation of Transforming Growth Factor

L. Myeroff, W. Grady, S. Swinler, 2013 .

Mutation detection in the TGF-beta receptors and smad genes: RT-PCR and sequencing.

L. Myeroff, S. Markowitz, S. Fink, 2000, Methods in molecular biology.

Detection of TGF-beta type II receptor hot-spot mutations: the BAT-RII assay.

L. Myeroff, S. Markowitz, 2000, Methods in molecular biology.

What's new with RII?

L. Myeroff, W. Grady, A. Rajput, 1997, Gastroenterology.

Chromosomal autonomy of hMLH1 methylation in colon cancer.

S. Schwartz, Hui Li, L. Myeroff, 2002 .

Two Distinct Categories of Focal Deletions in Cancer Genomes

Kathleen R. Cho, Michael Ruogu Zhang, A. Krasnitz, 2013, PloS one.

Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer.

K. Kinzler, B. Vogelstein, L. Myeroff, 1995, Cancer research.

A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability.

Kathleen R. Cho, K. Kinzler, B. Vogelstein, 1995, Cancer research.

H3K4me3 inversely correlates with DNA methylation at a large class of non-CpG-island-containing start sites

G. Crawford, L. Myeroff, J. Lutterbaugh, 2012, Genome Medicine.

Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.

L. Myeroff, T. P. Pretlow, L. Kasturi, 2005, Journal of the National Cancer Institute.

Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival

Jill S Barnholtz-Sloan, Nathan Morris, Joseph Willis, 2015, Oncotarget.

Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas.

L. Myeroff, J. Willis, S. Markowitz, 1998, Cancer research.

Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.

K. Kinzler, B. Vogelstein, L. Myeroff, 1999, Cancer research.

Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells (*)

Luzhe Sun, L. Myeroff, J. Willson, 1995, The Journal of Biological Chemistry.

A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene.

L. Myeroff, J. Lutterbaugh, J. Willson, 1994, The Journal of clinical investigation.

Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor‐beta signaling in mouse intestinal neoplasms

J. Davison, T. Scheetz, L. Myeroff, 2017, International journal of cancer.

Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential.

L. Myeroff, S. Markowitz, 1993, Journal of the National Cancer Institute.

Nm23--into the basement (membrane)

L. Myeroff, S. Markowitz, 1994, Journal of the National Cancer Institute.

Mutation Detection inTGF-β Receptors.

L. Myeroff, S. Markowitz, W. Grady, 2001, Methods in molecular medicine.

Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer.

K. Kinzler, B. Vogelstein, L. Myeroff, 1995, Cancer research.